Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.

24 total trials for this combination

Showing top 10 of 24 trials

Trials

NCT ID	Title	Status	Phase
NCT01720446	Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT02730377	Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes	COMPLETED	PHASE4
NCT03078478	A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs	COMPLETED	PHASE3
NCT01959529	A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events	COMPLETED	PHASE3
NCT02692716	A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT00294723	To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c	TERMINATED	PHASE3
NCT00982644	Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT01388361	Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin	COMPLETED	PHASE3
NCT02461589	Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE2
NCT03268005	Research Study Comparing a New Medicine Fast-acting Insulin Aspart to Another Already Available Medicine NovoRapid/NovoLog in People With Type 2 Diabetes	COMPLETED	PHASE3

Related Pages

All Diabetes trials All trials in Lancaster, United States